| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e035457406455ea05989c01cb90c8f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efe6b23ac8c54b61556ba911731fe752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6bfc683a4ed24624a20577e28ee2e5d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-525 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2004-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_998a9b6e02e0c8b5ff1f6c5649e1253e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0954a1bb2d6767fc2347d85d276484e8 |
| publicationDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005003785-A2 |
| titleOfInvention |
Anti-inflammatory assay and compounds |
| abstract |
A method of identifying new lead anti-inflammatory agents based on the use of MNK and its action on AREBP(s) and subsequent effect on TNFcc expression is provided. The invention also relates to novel anti-inflammatory agents which disrupt MNK activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167296-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10093660-B2 |
| priorityDate |
2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |